Companies: 10,795·Total market cap: $144.5T
Standard BioTools Inc.

Standard BioTools Inc.

LABNASDAQHealthcare● Active
$0.82
$-0.33(-29.03%)
Market Cap$318618452
P/E Ratio
52W High$1.72
52W Low$0.8081
Overview

Standard BioTools Inc. (LAB) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LAB · as of Jun 8, 2026

Activity summary

Buy transactions

24

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Standard BioTools Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

LAB insider buying and selling by quarter

LAB insider selling · LAB insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
11.2M5.6M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · LAB ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

LAB executive sell shares · LAB board member insider trading · LAB insider trading SEC filing

Showing 61 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Kim Hanjoon Alex

CFO

Other

Date

May 20

Shares

18,871

Price

$1.00

Value

$19K

View Form 4 on SEC.gov

Mackay Sean

SVP & Chief Business Officer

Other

Date

May 20

Shares

25,729

Price

$1.00

Value

$26K

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Other

Date

May 20

Shares

97,626

Price

$1.00

Value

$98K

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Option

Date

Apr 6

Shares

196,513

Price

Value

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Other

Date

Apr 6

Shares

95,014

Price

$0.91

Value

$86K

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Award

Date

Mar 20

Shares

1,042,373

Price

Value

View Form 4 on SEC.gov

Mackay Sean

SVP & Chief Business Officer

Award

Date

Mar 20

Shares

272,107

Price

Value

View Form 4 on SEC.gov

Kim Hanjoon Alex

CFO

Option

Date

Apr 6

Shares

70,183

Price

Value

View Form 4 on SEC.gov

Kim Hanjoon Alex

CFO

Other

Date

Apr 6

Shares

21,301

Price

$0.91

Value

$19K

View Form 4 on SEC.gov

Kim Hanjoon Alex

CFO

Award

Date

Mar 20

Shares

323,173

Price

Value

View Form 4 on SEC.gov

Casdin Eli

Director

Award

Date

Feb 26

Shares

52,991

Price

$1.17

Value

$62K

View Form 4 on SEC.gov

Cox Troy

Director

Award

Date

Feb 26

Shares

57,264

Price

$1.17

Value

$67K

View Form 4 on SEC.gov

Carey Thomas D.

Director

Award

Date

Feb 26

Shares

51,282

Price

$1.17

Value

$60K

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Other

Date

Feb 23

Shares

66,127

Price

$1.15

Value

$76K

View Form 4 on SEC.gov

Mackay Sean

SVP & Chief Business Officer

Other

Date

Feb 23

Shares

19,661

Price

$1.15

Value

$23K

View Form 4 on SEC.gov

Kim Hanjoon Alex

CFO

Other

Date

Feb 23

Shares

12,740

Price

$1.15

Value

$15K

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Other

Date

Nov 20

Shares

63,529

Price

$1.28

Value

$81K

View Form 4 on SEC.gov

Kim Hanjoon Alex

CFO

Other

Date

Nov 20

Shares

12,739

Price

$1.28

Value

$16K

View Form 4 on SEC.gov

Mackay Sean

SVP & Chief Business Officer

Other

Date

Nov 20

Shares

19,661

Price

$1.28

Value

$25K

View Form 4 on SEC.gov

Egholm Michael

President & CEO · Director

Other

Date

Aug 20

Shares

54,919

Price

$1.27

Value

$70K

View Form 4 on SEC.gov

Mackay Sean

SVP & Chief Business Officer

Other

Date

Aug 20

Shares

19,661

Price

$1.27

Value

$25K

View Form 4 on SEC.gov

Kim Hanjoon Alex

CFO

Other

Date

Aug 20

Shares

12,739

Price

$1.27

Value

$16K

View Form 4 on SEC.gov

Casdin Partners Master Fund, L.P.

Director

Purchase

Date

Aug 15

Shares

150,000

Price

$1.22

Value

$183K

View Form 4 on SEC.gov

Casdin Partners Master Fund, L.P.

Director

Purchase

Date

Aug 14

Shares

133,220

Price

$1.21

Value

$162K

View Form 4 on SEC.gov

Casdin Partners Master Fund, L.P.

Director

Purchase

Date

Aug 13

Shares

75,000

Price

$1.31

Value

$98K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LAB insider trading

LAB insider trades

Standard BioTools Inc. (LAB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Kim Hanjoon Alex (CFO), Egholm Michael (President & CEO · Director), Mackay Sean (SVP & Chief Business Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. LAB insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Standard BioTools Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

LAB insider trading · 5 questions

The insiders of Standard BioTools Inc. (LAB) include executives and directors such as Kim Hanjoon Alex (CFO), Egholm Michael (President & CEO · Director), Mackay Sean (SVP & Chief Business Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LAB board member insider tradingwho are LAB insidersLAB insider rosterStandard BioTools Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026